通年性アレルギー性鼻炎(Perennial Allergic Rhinitis)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Perennial Allergic Rhinitis Overview 6
Therapeutics Development 7
Pipeline Products for Perennial Allergic Rhinitis – Overview 7
Pipeline Products for Perennial Allergic Rhinitis – Comparative Analysis 8
Perennial Allergic Rhinitis – Therapeutics under Development by Companies 9
Perennial Allergic Rhinitis – Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Perennial Allergic Rhinitis – Products under Development by Companies 12
Perennial Allergic Rhinitis – Companies Involved in Therapeutics Development 13
Adamis Pharmaceuticals Corporation 13
FAES Farma SA 14
GenMont Biotech Inc. 15
GlaxoSmithKline plc 16
Hanmi Pharmaceuticals, Co. Ltd. 17
Merck & Co., Inc. 18
Pfizer Inc. 19
Shionogi & Co., Ltd. 20
VentiRx Pharmaceuticals, Inc. 21
Perennial Allergic Rhinitis – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Target 24
Assessment by Mechanism of Action 26
Assessment by Route of Administration 28
Assessment by Molecule Type 30
Drug Profiles 32
(montelukast sodium + levocetirizine dihydrochloride) – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
APC-3000 – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
bilastine – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
desloratadine – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
fluticasone furoate – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
GMNL-32 – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
PF-06444752 – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
PF-06444753 – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
S-555739 – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
VTX-1463 – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Perennial Allergic Rhinitis – Recent Pipeline Updates 44
Perennial Allergic Rhinitis – Dormant Projects 47
Perennial Allergic Rhinitis – Discontinued Products 48
Appendix 49
Methodology 49
Coverage 49
Secondary Research 49
Primary Research 49
Expert Panel Validation 49
Contact Us 50
Disclaimer 50